Synthesis and anti-angiogenesis activity of coumarin derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 17, 2006, Pages 4596-4599

  Lee, Seokjoon ^a,b   Sivakumar, Krishnamoorthy ^a   Shin, Woon Seob ^b   Xie, Fang ^a   Wang, Qian ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Anti angigenesis; Coumarin derivaties; Fluorescence; Imaging; Small molecule; Synthesis

Indexed keywords

ANGIOGENESIS INHIBITOR; COUMARIN DERIVATIVE; NITRILE; PACLITAXEL;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG SYNTHESIS; EMBRYO; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANGIOGENESIS INHIBITORS; CELL PROLIFERATION; CELLS, CULTURED; COUMARINS; HUMANS; MOLECULAR STRUCTURE;

EID: 33746206292     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.06.007     Document Type: Article

References (26)

1. Folkman J. Adv. Cancer Res. 43 (1985) 175
2. Arnold F., and West D.C. Pharmacol. Ther. 52 (1991) 407
3. Li L.Y., Barlow K.D., and Metheny-Barlow L.J. Pediatr. Endocrinol. Rev. 2 (2005) 399
4. Hyder S.M., and Stancel G.M. Mol. Endocrinol. 13 (1999) 806
5. Milkiewicz M., Ispanovic E., Doyle J.L., and Hass T.L. Int. J. Biochem. Cell Bio. 38 (2006) 333
6. Boui{dotless}̈s D., Kusumanto Y., Meijer C., Mulder N.H., and Hospers G.A.P. Pharm. Res. 53 (2006) 89
7. Hanahan D. Nat. Med. 49 (1998) 117
8. Hanahan D. Science 277 (1997) 48
9. Gomes A., Fernandes E., and Lima J.L.F.C. J. Biochem. Biophys. Methods 65 (2005) 45
10. Kobayashi M., Tajiri H., Seike E., Shitaya M., Tounou S., Mine M., and Oba K. Cancer Lett. 165 (2001) 155
11. Tozer G.M., Ameer-Beg S.M., Baker J., Barber P.R., Hill S.A., Hodgkiss R.J., Locke R., Prise V.E., Wilson I., and Vojnovic B. Adv. Drug Delivery Rev. 57 (2005) 135
12. Some current references:. Curini M., Cravotto G., Epifano F., and Giannone G. Curr. Med. Chem. 13 (2006) 199
13. Borges F., Roleira F., Milhazes N., Santana L., and Uriarte E. Curr. Med. Chem. 12 (2005) 887
14. Fylaktakidou K.C., Hadjipavlou-Litina D.J., Litinas K.E., and Nicolaides D.N. Curr. Pharm. Design 10 (2004) 3813
15. Xie L., Takeuchi Y., Cosentino L.M., McPhail A.T., and Lee K.-H. J. Med. Chem. 44 (2001) 664
16. Yang Z.Y., Xia Y., Xia P., Brossi A., Cosentino L.M., and Lee K.-H. Bioorg. Med. Chem. Lett. 10 (2000) 1003
17. Nam N.-H., Kim Y., You Y.-J., Hong D.-H., Kim H.-M., and Ahn B.-Z. Bioorg. Med. Chem. Lett. 12 (2002) 2345
18. Sivakumar K., Xie F., Cash B.M., Long S., Barnhill H.N., and Wang Q. Org. Lett. 6 (2004) 4603
19. Katerinopoulos H.E. Curr. Pharm. Design 10 (2004) 3835
20. U87 MG: human glioma; B16: mouse melanoma; HeLa; human cervical carcinoma; DLD-1: human colorectal adenocarcinoma; SiHa: human cervical carcinoma; NIH 3T3: mouse embryonic fibroblast cell line; HUVEC: human umbilical vein endothelial cell.
21. Mosmann T. J. Immunol. Methods 65 (1983) 55
22. Luo X., Naiyun X., Cheng L., and Huang D. Dyes and Pigments 51 (2001) 153
23. Moeckli P. Dyes and Pigments 1 (1980) 3
24. British patent 914 347, 1963.
25. Christie R.M., and Lui C.-H. Dyes and Pigments 47 (2000) 79
26. 3): δ 8.60 (s, 1H), 6.99 (s, 1H), 3.23 (m, 4H), 2.64-2.70 (m, 4H), 1.84-1.89 (m, 4H).